Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
2.
Nat Commun ; 13(1): 7444, 2022 12 02.
Article in English | MEDLINE | ID: mdl-36460641

ABSTRACT

Mechanisms by which specific histone modifications regulate distinct gene networks remain little understood. We investigated how H3K79me2, a modification catalyzed by DOT1L and previously considered a general transcriptional activation mark, regulates gene expression during cardiogenesis. Embryonic cardiomyocyte ablation of Dot1l revealed that H3K79me2 does not act as a general transcriptional activator, but rather regulates highly specific transcriptional networks at two critical cardiogenic junctures: embryonic cardiogenesis, where it was particularly important for left ventricle-specific genes, and postnatal cardiomyocyte cell cycle withdrawal, with Dot1L mutants having more mononuclear cardiomyocytes and prolonged cardiomyocyte cell cycle activity. Mechanistic analyses revealed that H3K79me2 in two distinct domains, gene bodies and regulatory elements, synergized to promote expression of genes activated by DOT1L. Surprisingly, H3K79me2 in specific regulatory elements also contributed to silencing genes usually not expressed in cardiomyocytes. These results reveal mechanisms by which DOT1L successively regulates left ventricle specification and cardiomyocyte cell cycle withdrawal.


Subject(s)
Gene Regulatory Networks , Myocytes, Cardiac , Cell Division , Cell Cycle/genetics , Heart Ventricles
3.
Acta Biomater ; 152: 47-59, 2022 10 15.
Article in English | MEDLINE | ID: mdl-36041648

ABSTRACT

As the native regenerative potential of adult cardiac tissue is limited post-injury, stimulating endogenous repair mechanisms in the mammalian myocardium is a potential goal of regenerative medicine therapeutics. Injection of myocardial matrix hydrogels into the heart post-myocardial infarction (MI) has demonstrated increased cardiac muscle and promotion of pathways associated with cardiac development, suggesting potential promotion of cardiomyocyte turnover. In this study, the myocardial matrix hydrogel was shown to have native capability as an effective reactive oxygen species scavenger and protect against oxidative stress induced cell cycle inhibition in vitro. Encapsulation of cardiomyocytes demonstrated an enhanced turnover in in vitro studies, and in vivo assessments of myocardial matrix hydrogel treatment post-MI showed increased thymidine analog uptake in cardiomyocyte nuclei compared to saline controls. Overall, this study provides evidence that properties of the myocardial matrix material provide a microenvironment mitigating oxidative damage and supportive of cardiomyocytes undergoing DNA synthesis, toward possible DNA repair or cell cycle activation. STATEMENT OF SIGNIFICANCE: Loss of adult mammalian cardiomyocyte turnover is influenced by shifts in oxidative damage, which represents a potential mechanism for improving restoration of cardiac muscle after myocardial infarction (MI). Injection of a myocardial matrix hydrogel into the heart post-MI previously demonstrated increased cardiac muscle and promotion of pathways associated with cardiac development, suggesting potential in promoting proliferation of cardiomyocytes. In this study, the myocardial matrix hydrogel was shown to protect cells from oxidative stress and increase proliferation in vitro. In a rat MI model, greater presence of tissue free thiol content spared from oxidative damage, lesser mitochondrial superoxide content, and increased thymidine analog uptake in cardiomyocytes was found in matrix injected animals compared to saline controls. Overall, this study provides evidence that properties of the myocardial matrix material provide a microenvironment supportive of cardiomyocytes undergoing DNA synthesis, toward possible DNA repair or cell cycle activation.


Subject(s)
Myocardial Infarction , Myocytes, Cardiac , Animals , DNA/metabolism , Hydrogels/metabolism , Hydrogels/pharmacology , Mammals , Myocardial Infarction/metabolism , Myocardium/metabolism , Rats , Reactive Oxygen Species/metabolism , Sulfhydryl Compounds/pharmacology , Superoxides , Thymidine/metabolism , Thymidine/pharmacology
5.
iScience ; 23(9): 101539, 2020 Sep 25.
Article in English | MEDLINE | ID: mdl-33083767

ABSTRACT

Enhancer RNAs (eRNAs) are a subset of long noncoding RNA generated from genomic enhancers: they are thought to act as potent promoters of the expression of nearby genes through interaction with the transcriptional and epigenomic machineries. In the present work, we describe two eRNAs transcribed from the enhancer of Nkx2-5-a gene specifying a master cardiomyogenic lineage transcription factor (TF)-which we call Intergenic Regulatory Element Nkx2-5 Enhancers (IRENEs). The IRENEs are encoded, respectively, on the same strand (SS) and in the divergent direction (div) respect to the nearby gene. Of note, these two eRNAs have opposing roles in the regulation of Nkx2-5: IRENE-SS acts as a canonical promoter of transcription, whereas IRENE-div represses the activity of the enhancer through recruitment of the histone deacetylase sirtuin 1. Thus, we have identified an autoregulatory loop controlling expression of the master cardiac TF NKX2-5, in which one eRNA represses transcription.

6.
Cell Rep ; 30(2): 571-582.e2, 2020 01 14.
Article in English | MEDLINE | ID: mdl-31940497

ABSTRACT

Despite decades of studies suggesting that the in vivo adipocyte progenitor resides within the vascular niche, the exact nature of this progenitor remains controversial because distinct studies have attributed adipogenic properties to multiple vascular cell types. Using Cre recombinases labeling distinct vascular lineages, we conduct parallel lineage tracing experiments to assess their degree of contribution to de novo adipogenesis. Although we detect occasional adipocytes that were lineage traced by endothelial or mural recombinases, these are rare events. On the other hand, platelet-derived growth factor receptor alpha (PDGFRα)-expressing adventitial or capsular fibroblasts make a significant contribution to adipocytes in all depots and experimental settings tested. Our data also suggest that fibroblasts transition to an intermediate beige adipocyte phenotype prior to differentiating to a mature white adipocyte. These observations, together with histological analyses revealing that adipose tissue fibroblasts express the mural cell marker PDGFRß, harmonize a highly controversial field with implications for multiple human diseases, including the pandemic of obesity.


Subject(s)
Adipogenesis/genetics , Adipose Tissue/metabolism , Cell Lineage/physiology , Fibroblasts/metabolism , Obesity/metabolism , Stem Cells/metabolism , Animals , Cell Differentiation , Humans
7.
Circulation ; 140(1): 55-66, 2019 07 02.
Article in English | MEDLINE | ID: mdl-30982350

ABSTRACT

BACKGROUND: Membrane contact sites are fundamental for transmission and translation of signals in multicellular organisms. The junctional membrane complexes in the cardiac dyads, where transverse (T) tubules are juxtaposed to the sarcoplasmic reticulum, are a prime example. T-tubule uncoupling and remodeling are well-known features of cardiac disease and heart failure. Even subtle alterations in the association between T-tubules and the junctional sarcoplasmic reticulum can cause serious cardiac disorders. NEXN (nexilin) has been identified as an actin-binding protein, and multiple mutations in the NEXN gene are associated with cardiac diseases, but the precise role of NEXN in heart function and disease is still unknown. METHODS: Nexn global and cardiomyocyte-specific knockout mice were generated. Comprehensive phenotypic and RNA sequencing and mass spectrometry analyses were performed. Heart tissue samples and isolated single cardiomyocytes were analyzed by electron and confocal microscopy. RESULTS: Global and cardiomyocyte-specific loss of Nexn in mice resulted in a rapidly progressive dilated cardiomyopathy. In vivo and in vitro analyses revealed that NEXN interacted with junctional sarcoplasmic reticulum proteins, was essential for optimal calcium transients, and was required for initiation of T-tubule invagination and formation. CONCLUSIONS: These results demonstrated that NEXN is a pivotal component of the junctional membrane complex and is required for initiation and formation of T-tubules, thus providing insight into mechanisms underlying cardiomyopathy in patients with mutations in NEXN.


Subject(s)
Cardiomyopathy, Dilated/metabolism , Cell Membrane/metabolism , Intercellular Junctions/metabolism , Microfilament Proteins/deficiency , Muscle Fibers, Skeletal/metabolism , Myocytes, Cardiac/metabolism , Animals , Calcium Channels, L-Type/metabolism , Cardiomyopathy, Dilated/genetics , Cardiomyopathy, Dilated/pathology , Cell Membrane/genetics , Cell Membrane/pathology , Cells, Cultured , Intercellular Junctions/genetics , Intercellular Junctions/pathology , Mice , Mice, Knockout , Mice, Transgenic , Microfilament Proteins/genetics , Muscle Fibers, Skeletal/pathology , Myocytes, Cardiac/pathology
10.
Circ Res ; 122(4): 583-590, 2018 02 16.
Article in English | MEDLINE | ID: mdl-29269349

ABSTRACT

RATIONALE: Myocardial infarction is a major cause of adult mortality worldwide. The origin(s) of cardiac fibroblasts that constitute the postinfarct scar remain controversial, in particular the potential contribution of bone marrow lineages to activated fibroblasts within the scar. OBJECTIVE: The aim of this study was to establish the origin(s) of infarct fibroblasts using lineage tracing and bone marrow transplants and a robust marker for cardiac fibroblasts, the Collagen1a1-green fluorescent protein reporter. METHODS AND RESULTS: Using genetic lineage tracing or bone marrow transplant, we found no evidence for collagen-producing fibroblasts derived from hematopoietic or bone marrow lineages in hearts subjected to permanent left anterior descending coronary artery ligation. In fact, fibroblasts within the infarcted area were largely of epicardial origin. Intriguingly, collagen-producing fibrocytes from hematopoietic lineages were observed attached to the epicardial surface of infarcted and sham-operated hearts in which a suture was placed around the left anterior descending coronary artery. CONCLUSIONS: In this controversial field, our study demonstrated that the vast majority of infarct fibroblasts were of epicardial origin and not derived from bone marrow lineages, endothelial-to-mesenchymal transition, or blood. We also noted the presence of collagen-producing fibrocytes on the epicardial surface that resulted at least in part from the surgical procedure.


Subject(s)
Bone Marrow Cells/cytology , Cell Lineage , Myocardial Infarction/therapy , Myofibroblasts/cytology , Animals , Bone Marrow Cells/metabolism , Bone Marrow Transplantation/adverse effects , Cells, Cultured , Collagen Type I/genetics , Collagen Type I/metabolism , Mice , Mice, Inbred C57BL , Myocardial Infarction/pathology , Myofibroblasts/metabolism , Myofibroblasts/pathology , Pericardium/cytology
11.
Cell Stem Cell ; 20(3): 345-359.e5, 2017 03 02.
Article in English | MEDLINE | ID: mdl-28111199

ABSTRACT

Pericytes are widely believed to function as mesenchymal stem cells (MSCs), multipotent tissue-resident progenitors with great potential for regenerative medicine. Cultured pericytes isolated from distinct tissues can differentiate into multiple cell types in vitro or following transplantation in vivo. However, the cell fate plasticity of endogenous pericytes in vivo remains unclear. Here, we show that the transcription factor Tbx18 selectively marks pericytes and vascular smooth muscle cells in multiple organs of adult mouse. Fluorescence-activated cell sorting (FACS)-purified Tbx18-expressing cells behaved as MSCs in vitro. However, lineage-tracing experiments using an inducible Tbx18-CreERT2 line revealed that pericytes and vascular smooth muscle cells maintained their identity in aging and diverse pathological settings and did not significantly contribute to other cell lineages. These results challenge the current view of endogenous pericytes as multipotent tissue-resident progenitors and suggest that the plasticity observed in vitro or following transplantation in vivo arises from artificial cell manipulations ex vivo.


Subject(s)
Mesenchymal Stem Cells/cytology , Organ Specificity , Pericytes/cytology , Adipocytes/cytology , Aging/genetics , Cell Lineage , Cicatrix/pathology , Fibroblasts/cytology , Gene Expression Regulation, Developmental , Green Fluorescent Proteins/metabolism , Humans , Integrases/metabolism , Mesenchymal Stem Cells/metabolism , Muscle Development , Muscle, Smooth, Vascular/cytology , Myocytes, Smooth Muscle/metabolism , Neurons/cytology , Pericytes/metabolism , Phenotype , Receptor, Platelet-Derived Growth Factor beta/metabolism , T-Box Domain Proteins/genetics , T-Box Domain Proteins/metabolism
13.
Cell Rep ; 14(1): 140-151, 2016 Jan 05.
Article in English | MEDLINE | ID: mdl-26725114

ABSTRACT

Arrhythmogenesis during heart failure is a major clinical problem. Regional electrical gradients produce arrhythmias, and cellular ionic transmembrane gradients are its originators. We investigated whether the nanoscale mechanosensitive properties of cardiomyocytes from failing hearts have a bearing upon the initiation of abnormal electrical activity. Hydrojets through a nanopipette indent specific locations on the sarcolemma and initiate intracellular calcium release in both healthy and heart failure cardiomyocytes, as well as in human failing cardiomyocytes. In healthy cells, calcium is locally confined, whereas in failing cardiomyocytes, calcium propagates. Heart failure progressively stiffens the membrane and displaces sub-sarcolemmal mitochondria. Colchicine in healthy cells mimics the failing condition by stiffening the cells, disrupting microtubules, shifting mitochondria, and causing calcium release. Uncoupling the mitochondrial proton gradient abolished calcium initiation in both failing and colchicine-treated cells. We propose the disruption of microtubule-dependent mitochondrial mechanosensor microdomains as a mechanism for abnormal calcium release in failing heart.


Subject(s)
Calcium Signaling , Heart Failure/metabolism , Mechanotransduction, Cellular , Microtubules/metabolism , Mitochondria, Heart/metabolism , Myocytes, Cardiac/metabolism , Calcium/metabolism , Cells, Cultured , Heart Failure/pathology , Humans , Microtubules/pathology , Mitochondria, Heart/pathology , Myocytes, Cardiac/pathology
14.
J Mol Cell Cardiol ; 91: 1-5, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26748307

ABSTRACT

Cardiac fibroblasts produce the extracellular matrix (ECM) scaffold within which the various cellular components of the heart are organized. As well as providing structural support, it is becoming evident that the quality and quantity of ECM is a key factor for determining cardiac cell behavior during development and in pathological contexts such as heart failure involving fibrosis. Cardiac fibroblasts have long remained a poorly characterized cardiac lineage. Well characterized markers are now paving the way for a better understanding of the roles of these cells in various developmental and disease contexts. Notably, the relevance of processes including endothelial-tomesenchymal transition and the recruitment of circulating fibroblast progenitors in heart failure has been challenged. This review describes the latest findings on cardiac fibroblast markers and developmental origins, and discusses their importance in myocardial remodeling. Effective modulation of cardiac fibroblast activity would likely contribute to successful treatment of various cardiac disorders.


Subject(s)
Cell Lineage/physiology , Fibroblasts/pathology , Heart Failure/pathology , Myocardium/pathology , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/metabolism , Biomarkers/metabolism , Collagen Type I/genetics , Collagen Type I/metabolism , Discoidin Domain Receptors , Extracellular Matrix/metabolism , Fibroblasts/metabolism , Fibrosis , Gene Expression , Heart Failure/genetics , Heart Failure/metabolism , Humans , Myocardium/metabolism , Receptor Protein-Tyrosine Kinases/genetics , Receptor Protein-Tyrosine Kinases/metabolism , Receptor, Platelet-Derived Growth Factor beta/genetics , Receptor, Platelet-Derived Growth Factor beta/metabolism , Receptors, Mitogen/genetics , Receptors, Mitogen/metabolism , T-Box Domain Proteins/genetics , T-Box Domain Proteins/metabolism
15.
J Clin Invest ; 125(8): 3256-68, 2015 Aug 03.
Article in English | MEDLINE | ID: mdl-26193633

ABSTRACT

The sinoatrial node (SAN) maintains a rhythmic heartbeat; therefore, a better understanding of factors that drive SAN development and function is crucial to generation of potential therapies, such as biological pacemakers, for sinus arrhythmias. Here, we determined that the LIM homeodomain transcription factor ISL1 plays a key role in survival, proliferation, and function of pacemaker cells throughout development. Analysis of several Isl1 mutant mouse lines, including animals harboring an SAN-specific Isl1 deletion, revealed that ISL1 within SAN is a requirement for early embryonic viability. RNA-sequencing (RNA-seq) analyses of FACS-purified cells from ISL1-deficient SANs revealed that a number of genes critical for SAN function, including those encoding transcription factors and ion channels, were downstream of ISL1. Chromatin immunoprecipitation assays performed with anti-ISL1 antibodies and chromatin extracts from FACS-purified SAN cells demonstrated that ISL1 directly binds genomic regions within several genes required for normal pacemaker function, including subunits of the L-type calcium channel, Ank2, and Tbx3. Other genes implicated in abnormal heart rhythm in humans were also direct ISL1 targets. Together, our results demonstrate that ISL1 regulates approximately one-third of SAN-specific genes, indicate that a combination of ISL1 and other SAN transcription factors could be utilized to generate pacemaker cells, and suggest ISL1 mutations may underlie sick sinus syndrome.


Subject(s)
Cell Proliferation/physiology , Gene Expression Regulation, Developmental/physiology , LIM-Homeodomain Proteins/metabolism , Myocardial Contraction/physiology , Sinoatrial Node/embryology , Transcription Factors/metabolism , Animals , Ankyrins/genetics , Ankyrins/metabolism , Cell Survival , Chromatin/genetics , Chromatin/metabolism , Gene Deletion , LIM-Homeodomain Proteins/genetics , Mice , Mice, Transgenic , Protein Binding , Sick Sinus Syndrome/embryology , Sick Sinus Syndrome/genetics , Sick Sinus Syndrome/pathology , Sinoatrial Node/cytology , T-Box Domain Proteins/genetics , T-Box Domain Proteins/metabolism , Transcription Factors/genetics
16.
Dev Cell ; 33(5): 507-21, 2015 Jun 08.
Article in English | MEDLINE | ID: mdl-26028220

ABSTRACT

Transcriptional mediators of cell stress pathways, including HIF1α, ATF4, and p53, are key to normal development and play critical roles in disease, including ischemia and cancer. Despite their importance, mechanisms by which pathways mediated by these transcription factors interact with one another are not fully understood. In addressing the controversial role of HIF1α in cardiomyocytes (CMs) during heart development, we discovered a mid-gestational requirement for HIF1α for proliferation of hypoxic CMs, involving metabolic switching and a complex interplay among HIF1α, ATF4, and p53. Loss of HIF1α resulted in activation of ATF4 and p53, the latter inhibiting CM proliferation. Bioinformatic and biochemical analyses revealed unexpected mechanisms by which HIF1α intersects with ATF4 and p53 pathways. Our results highlight previously undescribed roles of HIF1α and interactions among major cell stress pathways that could be targeted to enhance proliferation of CMs in ischemia and may have relevance to other diseases, including cancer.


Subject(s)
Activating Transcription Factor 4/metabolism , Cell Proliferation , Embryo, Mammalian/cytology , Fetus/cytology , Hypoxia-Inducible Factor 1, alpha Subunit/physiology , Hypoxia/physiopathology , Myocytes, Cardiac/cytology , Tumor Suppressor Protein p53/metabolism , Activating Transcription Factor 4/genetics , Animals , Biomarkers/metabolism , Blotting, Western , Cells, Cultured , Embryo, Mammalian/metabolism , Female , Fetus/metabolism , Flow Cytometry , Fluorescent Antibody Technique , Gene Expression Profiling , Immunoenzyme Techniques , Male , Mice , Mice, Knockout , Myocytes, Cardiac/metabolism , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Tumor Suppressor Protein p53/genetics
17.
Proc Natl Acad Sci U S A ; 110(50): 20164-9, 2013 Dec 10.
Article in English | MEDLINE | ID: mdl-24284169

ABSTRACT

Cardiac hypertrophy, initially an adaptive response of the myocardium to stress, can progress to heart failure. The epigenetic signature underlying this phenomenon is poorly understood. Here, we report on the genome-wide distribution of seven histone modifications in adult mouse cardiomyocytes subjected to a prohypertrophy stimulus in vivo. We found a set of promoters with an epigenetic pattern that distinguishes specific functional classes of genes regulated in hypertrophy and identified 9,207 candidate active enhancers whose activity was modulated. We also analyzed the transcriptional network within which these genetic elements act to orchestrate hypertrophy gene expression, finding a role for myocyte enhancer factor (MEF)2C and MEF2A in regulating enhancers. We propose that the epigenetic landscape is a key determinant of gene expression reprogramming in cardiac hypertrophy and provide a basis for understanding the role of chromatin in regulating this phenomenon.


Subject(s)
Cardiomegaly/genetics , Epigenesis, Genetic/genetics , Gene Expression Regulation, Developmental/genetics , Histones/metabolism , Transcription Factors/metabolism , Acetylation , Animals , Cardiomegaly/metabolism , Enhancer Elements, Genetic/genetics , Methylation , Mice , Promoter Regions, Genetic/genetics , Transcription Factors/genetics
18.
Atherosclerosis ; 212(1): 100-6, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20557886

ABSTRACT

BACKGROUND: An increasing body of evidence suggests that testosterone may exert beneficial effects against the development of atherosclerosis. These effects are thought to be the consequence of its conversion into estradiol and the activation of the estrogen receptors; however a direct role of androgens, such as dihydrotestosterone, has also been proposed. More recently, it has been shown that the transformation of the dihydrotestosterone to 5alpha-androstane-3alpha,17beta-diol (3alpha-diol) and 5alpha-androstane-3beta,17beta-diol (3beta-Adiol), generates two molecules unable to bind the androgen receptor, but with a high affinity for the estrogen receptors (ERs) in particular the beta isoform. As the actions of testosterone may result from the balance between androgenic and estrogenic molecules originating from its catabolism, we investigated the effects of the 3beta-Adiol on inflammatory responses in vitro in human endothelial cells and ex vivo in mice aortas. METHODS AND RESULTS: 3beta-Adiol reverts the pro-inflammatory gene expression pattern induced by TNF-alpha in HUVECs as determined by a cDNA microrray approach. Q-real-time PCR and protein array approaches confirmed that TNF-alpha-induced ICAM-1, VCAM-1 and ELAM-1 as well as MCP-1 and IL-6 induction was affected upon 3beta-Adiol pre-incubation. ICI 182780, an estrogen receptor antagonist and R,R-THC, an estrogen receptor beta antagonist, counteracted the effect of 3beta-Adiol while bicalutamide, an androgen receptor antagonist, had minor effects. 3beta-Adiol exerted a similar action on macrophages. Finally in castrated male mice, 3beta-Adiol significantly counteracted the LPS mediated mRNA induction of IL-6, ELAM-1and PECAM-1 in the aortas. CONCLUSION: 3beta-Adiol reverts in vitro the TNF-alpha and LPS induced pro-inflammatory activation of endothelial cells and macrophages. 3beta-Adiol in vivo modulates the inflammatory response induced by LPS in the arterial vascular wall.


Subject(s)
Androstane-3,17-diol/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Aorta/drug effects , Endothelial Cells/drug effects , Inflammation Mediators/metabolism , Inflammation/prevention & control , Lipopolysaccharides/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Androgen Antagonists/pharmacology , Animals , Aorta/immunology , Endothelial Cells/immunology , Estrogen Antagonists/pharmacology , Gene Expression Profiling/methods , Gene Expression Regulation/drug effects , Humans , Inflammation/genetics , Inflammation/immunology , Macrophages/drug effects , Macrophages/immunology , Male , Mice , Mice, Inbred C57BL , Oligonucleotide Array Sequence Analysis , Orchiectomy , Protein Array Analysis , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , U937 Cells
19.
J Cell Biol ; 187(7): 1101-16, 2009 Dec 28.
Article in English | MEDLINE | ID: mdl-20038681

ABSTRACT

Neural cell adhesion molecule (NCAM) associates with fibroblast growth factor (FGF) receptor-1 (FGFR1). However, the biological significance of this interaction remains largely elusive. In this study, we show that NCAM induces a specific, FGFR1-mediated cellular response that is remarkably different from that elicited by FGF-2. In contrast to FGF-induced degradation of endocytic FGFR1, NCAM promotes the stabilization of the receptor, which is recycled to the cell surface in a Rab11- and Src-dependent manner. In turn, FGFR1 recycling is required for NCAM-induced sustained activation of various effectors. Furthermore, NCAM, but not FGF-2, promotes cell migration, and this response depends on FGFR1 recycling and sustained Src activation. Our results implicate NCAM as a nonconventional ligand for FGFR1 that exerts a peculiar control on the intracellular trafficking of the receptor, resulting in a specific cellular response. Besides introducing a further level of complexity in the regulation of FGFR1 function, our findings highlight the link of FGFR recycling with sustained signaling and cell migration and the critical role of these events in dictating the cellular response evoked by receptor activation.


Subject(s)
Neural Cell Adhesion Molecules/metabolism , Receptor, Fibroblast Growth Factor, Type 1/metabolism , Animals , Cell Line , Cell Membrane/metabolism , Cell Movement , Fibroblast Growth Factor 2/metabolism , HeLa Cells , Humans , Ligands , Mice , Protein Transport , RNA Interference , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...